BioCentury
ARTICLE | Financial News

Nuvelution debuts with funding from Clarus, Novo A/S

July 14, 2015 1:25 AM UTC

Nuvelution Pharma Inc. (San Francisco, Calif.) debuted on Monday with an undisclosed investment from Clarus Ventures and Novo A/S (Hellerup, Denmark). Nuvelution plans to form risk-sharing partnership with biotech and pharma companies in which Nuvelution will spend $50-$500 million to fund and run clinical trials of a partner's molecule. ...